AU2928789A – Low ph pharmaceutical compositions of recombinant beta-interferon
– Google Patents
AU2928789A – Low ph pharmaceutical compositions of recombinant beta-interferon
– Google Patents
Low ph pharmaceutical compositions of recombinant beta-interferon
Info
Publication number
AU2928789A
AU2928789A
AU29287/89A
AU2928789A
AU2928789A
AU 2928789 A
AU2928789 A
AU 2928789A
AU 29287/89 A
AU29287/89 A
AU 29287/89A
AU 2928789 A
AU2928789 A
AU 2928789A
AU 2928789 A
AU2928789 A
AU 2928789A
Authority
AU
Australia
Prior art keywords
interferon
low
pharmaceutical compositions
recombinant beta
recombinant
Prior art date
1987-12-10
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU29287/89A
Inventor
Susan I. Hershenson
Jody Thomson
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis Vaccines and Diagnostics Inc
Original Assignee
Cetus Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
1987-12-10
Filing date
1988-12-02
Publication date
1989-07-05
1988-12-02
Application filed by Cetus Corp
filed
Critical
Cetus Corp
1989-07-05
Publication of AU2928789A
publication
Critical
patent/AU2928789A/en
Status
Abandoned
legal-status
Critical
Current
Links
Espacenet
Global Dossier
Discuss
Classifications
A—HUMAN NECESSITIES
A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
A61K9/00—Medicinal preparations characterised by special physical form
A61K9/0012—Galenical forms characterised by the site of application
A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
A—HUMAN NECESSITIES
A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
A61K47/02—Inorganic compounds
A—HUMAN NECESSITIES
A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
C—CHEMISTRY; METALLURGY
C07—ORGANIC CHEMISTRY
C07K—PEPTIDES
C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
C07K14/52—Cytokines; Lymphokines; Interferons
C07K14/555—Interferons [IFN]
C07K14/565—IFN-beta
A—HUMAN NECESSITIES
A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
A61K38/00—Medicinal preparations containing peptides
AU29287/89A
1987-12-10
1988-12-02
Low ph pharmaceutical compositions of recombinant beta-interferon
Abandoned
AU2928789A
(en)
Applications Claiming Priority (2)
Application Number
Priority Date
Filing Date
Title
US131375
1987-12-10
US07/131,375
US5004605A
(en)
1987-12-10
1987-12-10
Low pH pharmaceutical compositions of recombinant β-interferon
Publications (1)
Publication Number
Publication Date
AU2928789A
true
AU2928789A
(en)
1989-07-05
Family
ID=22449188
Family Applications (1)
Application Number
Title
Priority Date
Filing Date
AU29287/89A
Abandoned
AU2928789A
(en)
1987-12-10
1988-12-02
Low ph pharmaceutical compositions of recombinant beta-interferon
Country Status (4)
Country
Link
US
(1)
US5004605A
(en)
AU
(1)
AU2928789A
(en)
CA
(1)
CA1335255C
(en)
WO
(1)
WO1989005158A1
(en)
Families Citing this family (31)
* Cited by examiner, † Cited by third party
Publication number
Priority date
Publication date
Assignee
Title
US5183746A
(en)
*
1986-10-27
1993-02-02
Schering Aktiengesellschaft
Formulation processes for pharmaceutical compositions of recombinant β-
JPH05963A
(en)
*
1990-04-13
1993-01-08
Toray Ind Inc
Polypeptide composition
US5641868A
(en)
*
1991-04-18
1997-06-24
Toray Industries, Inc.
Interlekin-6 compositions, and a production process thereof
FR2684878B1
(en)
*
1991-12-12
1994-02-11
Roussel Uclaf
STABILIZED PHARMACEUTICAL COMPOSITION OF RECOMBINANT, NON-GLYCOSYLATED HUMAN IL2 IN REDUCED FORM AND PROCESS FOR PREPARING THE SAME.
EP0551535A1
(en)
*
1992-01-13
1993-07-21
SCLAVO S.p.A.
Process for the purification of recombinant human beta interferon, beta interferon thus purified, and pharmaceutical compositions which contain them
US5951974A
(en)
*
1993-11-10
1999-09-14
Enzon, Inc.
Interferon polymer conjugates
DK0730470T3
(en)
*
1993-11-10
2002-06-03
Enzon Inc
Improved interferon polymer conjugates
IT1272252B
(en)
*
1994-05-16
1997-06-16
Applied Research Systems
LIQUID FORMULATIONS OF INTERFERONE BETA
ES2245780T3
(en)
1994-05-18
2006-01-16
Nektar Therapeutics
METHODS AND COMPOSITIONS FOR THE FORMULATION OF INTERFERONS AS A DRY POWDER.
US6399296B1
(en)
*
1994-07-20
2002-06-04
The General Hospital Corporation
Interaction trap systems for detecting protein interactions
US5738846A
(en)
*
1994-11-10
1998-04-14
Enzon, Inc.
Interferon polymer conjugates and process for preparing the same
US5723125A
(en)
*
1995-12-28
1998-03-03
Tanox Biosystems, Inc.
Hybrid with interferon-alpha and an immunoglobulin Fc linked through a non-immunogenic peptide
US20030026779A1
(en)
*
1999-10-15
2003-02-06
Liming Yu
Treatment of tumors and viral infections with a hybrid conjugate of interferon and an immunoglobulin Fc
US20050002902A1
(en)
*
1995-12-28
2005-01-06
Liming Yu
Hybrid with interferon-alpha and an immunoglobulin Fc for treatment of tumors and viral infections
US6509313B1
(en)
*
1996-02-28
2003-01-21
Cornell Research Foundation, Inc.
Stimulation of immune response with low doses of cytokines
US20030190307A1
(en)
*
1996-12-24
2003-10-09
Biogen, Inc.
Stable liquid interferon formulations
JP4293497B2
(en)
1997-09-23
2009-07-08
レントシュレール ビオテクノロジー ゲー・エム・ベー・ハー
Interferon-β liquid composition
US5985263A
(en)
*
1997-12-19
1999-11-16
Enzon, Inc.
Substantially pure histidine-linked protein polymer conjugates
US5981709A
(en)
*
1997-12-19
1999-11-09
Enzon, Inc.
α-interferon-polymer-conjugates having enhanced biological activity and methods of preparing the same
TR200101086T2
(en)
1998-10-16
2001-08-21
Biogen, Inc.
Polymer compounds and uses of Interferon beta-1A.
US6465425B1
(en)
*
2000-02-10
2002-10-15
Alkermes Controlled Therapeutics, Inc.
Microencapsulation and sustained release of biologically active acid-stable or free sulfhydryl-containing proteins
US7544354B2
(en)
*
2000-10-27
2009-06-09
Novartis Vaccines And Diagnostics
Methods of protein purification and recovery
CA2428144C
(en)
2000-11-07
2012-01-10
Chiron Corporation
Compositions of interferon-beta stabilized with highly purified mannitol
US6887462B2
(en)
*
2001-04-09
2005-05-03
Chiron Corporation
HSA-free formulations of interferon-beta
AR034749A1
(en)
*
2001-07-09
2004-03-17
Schering Ag
FORMULATIONS OF HUMAN BETA INTERFERON
US8129330B2
(en)
*
2002-09-30
2012-03-06
Mountain View Pharmaceuticals, Inc.
Polymer conjugates with decreased antigenicity, methods of preparation and uses thereof
US20060074014A1
(en)
*
2002-11-18
2006-04-06
Vicuron Pharmaceuticals Inc.
Dalbavancin compositions for treatment of bacterial infections
EP1565201B1
(en)
*
2002-11-18
2018-10-31
Vicuron Pharmaceuticals, Inc.
Methods of administering dalbavancin for treatment of bacterial infections
US20040136952A1
(en)
*
2002-12-26
2004-07-15
Mountain View Pharmaceuticals, Inc.
Polymer conjugates of cytokines, chemokines, growth factors, polypeptide hormones and antagonists thereof with preserved receptor-binding activity
EA008866B1
(en)
*
2002-12-26
2007-08-31
Маунтин Вью Фамэсьютикэлс, Инк.
POLYMER CONJUGATES OF INTERFERON-β, PHARMACEUTICAL PRODUCTS BASED THEREON AND METHOD FOR THE PRODUCTION THEREOF
WO2009045553A1
(en)
*
2007-10-05
2009-04-09
Barofold, Inc.
High pressure treatment of aggregated interferons
Family Cites Families (28)
* Cited by examiner, † Cited by third party
Publication number
Priority date
Publication date
Assignee
Title
US4289689A
(en)
*
1980-03-14
1981-09-15
Hoffmann-La Roche Inc.
Preparation of homogeneous human fibroblast interferon
DE2943016C2
(en)
*
1979-10-24
1984-09-06
Dr. Rentschler Arzneimittel Gmbh & Co, 7958 Laupheim
Process for purifying interferon
US4460574A
(en)
*
1980-06-16
1984-07-17
Yabrov Alexander A
Prophylaxis or treatment of interferon-sensitive diseases
US4507281A
(en)
*
1981-10-13
1985-03-26
Exovir, Inc.
Interferon-containing compositions
EP0080879B1
(en)
*
1981-11-28
1986-10-01
Sunstar Kabushiki Kaisha
Pharmaceutical composition containing interferon in stable state
EP0082481B2
(en)
*
1981-12-23
1990-09-12
Schering Corporation
Stabilised alpha-interferon formulations and their preparation
US4450103A
(en)
*
1982-03-01
1984-05-22
Cetus Corporation
Process for recovering human IFN-β from a transformed microorganism
AU1234383A
(en)
*
1982-03-17
1983-09-22
Inter-Yeda Ltd.
Interferon stabilised with polyvinyl-pyrrolidone
ATE37983T1
(en)
*
1982-04-22
1988-11-15
Ici Plc
DELAYED RELEASE AGENT.
JPS5910524A
(en)
*
1982-07-08
1984-01-20
Toray Ind Inc
Interferon composition and its preparation
US4462940A
(en)
*
1982-09-23
1984-07-31
Cetus Corporation
Process for the recovery of human β-interferon-like polypeptides
EP0123291A2
(en)
*
1983-04-20
1984-10-31
Kyowa Hakko Kogyo Co., Ltd.
Method for stabilizing interferon
DE3325223A1
(en)
*
1983-07-13
1985-01-24
Hoechst Ag, 6230 Frankfurt
AGAINST AGAINST DENATURATION, AQUEOUS PROTEIN SOLUTIONS, METHODS FOR THEIR PRODUCTION AND THEIR USE
EP0133767B1
(en)
*
1983-08-04
1991-04-03
The Green Cross Corporation
Gamma interferon composition
JPS6061535A
(en)
*
1983-08-24
1985-04-09
エフ・ホフマン・ラ・ロシユ・ウント・コンパニ−・アクチエンゲゼルシヤフト
Pharmaceutical composition
US4680175A
(en)
*
1984-02-07
1987-07-14
Interferon Sciences, Inc.
Interferon administration vehicles
US4530787A
(en)
*
1984-03-28
1985-07-23
Cetus Corporation
Controlled oxidation of microbially produced cysteine-containing proteins
US4604377A
(en)
*
1984-03-28
1986-08-05
Cetus Corporation
Pharmaceutical compositions of microbially produced interleukin-2
EP0158487B1
(en)
*
1984-04-09
1991-08-28
Takeda Chemical Industries, Ltd.
Stable composition of interleukin-2
JPS60243028A
(en)
*
1984-04-28
1985-12-03
Kyowa Hakko Kogyo Co Ltd
Solubilization of interferon
EP0168008A3
(en)
*
1984-07-10
1986-12-30
Takeda Chemical Industries, Ltd.
Stable composition of gamma-interferon
US4606917A
(en)
*
1984-10-03
1986-08-19
Syntex (U.S.A) Inc.
Synergistic antiviral composition
EP0196203A3
(en)
*
1985-03-25
1987-09-30
Schering Corporation
Stable gamma interferon formulation
JPS61293926A
(en)
*
1985-06-21
1986-12-24
Toray Ind Inc
Interleukin-2 composition
JP2524586B2
(en)
*
1985-06-26
1996-08-14
シタス コーポレイション
Solubilization of proteins for pharmaceutical compositions utilizing polymer conjugation
US4933433A
(en)
*
1986-01-31
1990-06-12
E. I. Du Pont De Nemours And Company
Recombinant interleukin-2 composition and process for making it
IL83350A0
(en)
*
1986-08-13
1987-12-31
Takeda Chemical Industries Ltd
Pharmaceutical compositions comprising interleukin and intterferon active substances
CA1294215C
(en)
*
1986-10-27
1992-01-14
Ze’ev Shaked
Pharmaceutical compositions of recombinant beta-interferon and formulation processes
1987
1987-12-10
US
US07/131,375
patent/US5004605A/en
not_active
Expired – Lifetime
1988
1988-12-02
AU
AU29287/89A
patent/AU2928789A/en
not_active
Abandoned
1988-12-02
WO
PCT/US1988/004307
patent/WO1989005158A1/en
unknown
1988-12-07
CA
CA000585206A
patent/CA1335255C/en
not_active
Expired – Lifetime
Also Published As
Publication number
Publication date
CA1335255C
(en)
1995-04-18
US5004605A
(en)
1991-04-02
WO1989005158A1
(en)
1989-06-15
Similar Documents
Publication
Publication Date
Title
AU2928789A
(en)
1989-07-05
Low ph pharmaceutical compositions of recombinant beta-interferon
AU2535188A
(en)
1989-04-18
Pharmaceutical compositions of recombinant beta-interferon and formulation processes
AU2724088A
(en)
1989-04-18
Pharmaceutical compositions of recombinant interleukin-2 and formulation processes
EP0183503A3
(en)
1988-01-07
Conjugates of pharmaceutically useful proteins
AU7984287A
(en)
1988-04-21
Proteins of aids envelope gene
NZ213563A
(en)
1991-08-27
Anticoagulant proteins and pharmaceutical compositions
AU8292287A
(en)
1988-06-23
Purification of recombinant beta-interferon incorporating rp-hplc
AU581010B2
(en)
1989-02-09
Novel pharmaceutical use of (NVA)«-cyclosporine
AU626147B2
(en)
1992-07-23
Fibrinolytic proteins
IL84268A
(en)
1992-09-06
Amino-cyclohexyl-hydroxyalkanoic acid peptide derivatives and pharmaceutical compositions containing them
IL87800A0
(en)
1989-03-31
Dioxolane-2-carboxylic acids and pharmaceutical compositions comprising them
IL74661A0
(en)
1985-06-30
Preparation of proteins
AU628664B2
(en)
1992-09-17
Cephalosporin compound and pharmaceutical composition thereof
AU1925488A
(en)
1989-02-09
Pharmaceutical compositions
AU4033985A
(en)
1985-10-03
Compositions of calcitonin-gene related peptide
AU7468887A
(en)
1988-01-07
Composition for parenteral administration of proteins
AU1567888A
(en)
1988-11-10
New ophtalmological composition of matter
AU6643690A
(en)
1991-05-16
Polypeptide inhibitors of gamma interferon
PT83279A
(en)
1986-09-01
Process for the preparation of peptide antibiotics and of pharmaceutical compositions therewith
AU1928988A
(en)
1989-01-27
Pharmaceutical compositions
AU575386B2
(en)
1988-07-28
Pharmaceutical compositions of 4-oxo or 4-hydroxy-13-cis-vitamin
AU2117388A
(en)
1989-04-27
Recombinant htlv-iii proteins and uses thereof
IL74190A0
(en)
1985-04-30
6-substituted methylene-and hydroxymethylene-penicillanic acids and derivatives thereof and pharmaceutical compositions containing them
AU1635588A
(en)
1988-11-24
Pharmaceutical compositions
AU1996388A
(en)
1989-01-30
Proteins and protein compositions and their use
None